Pharma Industry News Archive

Pharma Industry News: June 2009

June 1 AstraZeneca and Merck & Co., Inc. Form Pioneering Collaboration to Investigate Novel Combination Anticancer Regimen
June 2 Pfizer Discontinues SUN 1094 Trial of Sunitinib plus Paclitaxel in Advanced Breast Cancer
June 2 Genzyme Completes Transaction with Bayer HealthCare
June 2 TorreyPines Therapeutics Announces its Board of Directors' Approval of Plan of Liquidation and Dissolution
June 2 FDA Warnings About Antidepressants Associated With Lasting, Unintended Changes in Diagnosis and Treatment
June 2 Drug Industry Marketing Direct to Consumers and Doctors May Lead to Prescription Overuse
June 2 PharmaLive.com Launches New Report on DTC Ad Spending
June 2 Concert Pharmaceuticals and GlaxoSmithKline Form Alliance to Develop Novel Deuterium Modified Drugs
June 2 Bio-Imaging Technologies and etrials Worldwide Merger Agreement Terminated
June 3 Advaxis Receives FDA Response to Orphan Drug Filing
June 3 FDA Forms Transparency Task Force
June 3 Almotriptan (Axert/Almogran) Approved by the FDA for the Treatment of Migraine in Adolescents
June 3 Pfizer Announces Completion Of European Debt Offering
June 3 FDA MedWatch - Propylthiouracil (PTU) associated with risk of serious liver injury, including liver failure and death
June 3 Genmab Announces Partial Clinical Hold on Zalutumumab Studies
June 4 Adolor Corporation Announces Staff Reductions and Restructuring
June 4 FDA Warns About Serious Liver Injury Associated With Anti-Thyroid Drug
June 4 Abbott and AstraZeneca Extend Relationship to Include Co-Promotion of Trilipix (fenofibric acid)
June 4 Anadys Pharmaceuticals, Inc. Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598
June 4 Johnson & Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs
June 5 Potential Signals of Serious Risks/New Safety Information Identified from the Adverse Event Reporting System (AERS) between October - December 2008
June 8 Aileron Therapeutics Closes $40 Million Series D Financing
June 8 Jean-Philippe Santoni Appointed Senior Vice President, Industrial Development and Innovation
June 8 EU-wide Recall of Raptiva (efalizumab) to be Initiated
June 8 Sanofi-aventis to Purchase Diabel Manufacturing Facility in Frankfurt to Strengthen Insulin Production Capacities
June 8 Alder Biopharmaceuticals Announces Expanded Collaboration With Schering-Plough
June 8 Commonwealth Biotechnologies, Inc. Announces Agreement to Acquire GL Biochem (Shanghai) Ltd
June 9 CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement
June 9 House Committee on Energy and Commerce Chairman Waxman Writes President Obama Regarding Generic Biologics
June 9 Progenics Provides Update on Hepatitis C Program
June 9 Merck & Co.: Corporations Need to Tackle Global Corruption as Strategic CSR Effort
June 9 GSK and Shenzhen Neptunus Create New Alliance to Develop and Manufacture Influenza Vaccines in China
June 9 NAACP & Nine Class Reps File Motion for Class Certification Against Eli Lilly in Pervasive Discrimination Case
June 10 Robert A. McDonald Elected President and Chief Executive of P&G
June 11 Xenon Enters Cardiovascular Disease Collaboration With Merck & Co., Inc.
June 11 FTC Releases Report on ?Follow-on Biologic Drug Competition?
June 11 Neuromed Announces that Merck & Co., Inc. Terminates Research Collaboration and License Agreement for Compounds Targeting N-Type Calcium Channels
June 11 TNS Media Intelligence Reports U.S. Advertising Expenditures Declined 14.2 Percent First Quarter 2009
June 11 Commonwealth Biotechnologies, Inc. Provides Market Update on Contemplated Acquisition of GL Biochem
June 12 Cumberland Pharmaceuticals Announces FDA Approval of Caldolor
June 12 ImmunoGen, Inc. Elects to Discontinue Further Internal Development of Its IMGN242 Compound
June 12 Oscient Pharmaceuticals Discontinues Sales Force Promotion for Antara and Factive
June 12 Genaera Corporation Board of Directors Dissolves Corporation and Forms Liquidating Trust
June 12 61% of American Adults Look Online for Health Information
June 15 Boehringer Ingelheim and Vitae Pharmaceuticals Announce a Major Collaboration to Research and Develop Novel Treatments for Alzheimer`s disease
June 15 Synta and GSK End Elesclomol Collaboration Agreement
June 15 Dr. Reddy's Announces Strategic Alliance with GSK for Emerging Markets
June 16 FDA Issues Safety Communication about an Ongoing Review of Stimulant Medications Used in Children with ADHD
June 16 FDA Warns Web Sites Against Marketing Fraudulent H1N1 Flu Virus Claims
June 16 Eli Lilly and Company Announces New Drug Discovery Initiative
June 16 Genzyme Temporarily Interrupts Production at Allston Plant
June 16 Adimab Launches Novel Antibody Discovery Platform and Announces Discovery Programs with Merck and Roche
June 17 Watson to Acquire Arrow Group
June 17 Biogen Idec Announces Conclusion of Arbitration with Genentech
June 17 Health Care Reform May Force U.S. Pharmaceutical Companies to Overhaul Sales Strategies, Says New Report From ZS Associates and eyeforpharma
June 18 Manhattan Pharmaceuticals Provides Corporate Update on Hedrin and Management Restructuring
June 18 Cefepime (marketed as Maxipime) Update of Ongoing Safety Review
June 18 S&P: Europe's Pharmaceutical Firms Buck The Recession With Strong Sales Growth In 2009, Says Report
June 19 FDA Grants The Medicines Company Pediatric Exclusivity for Angiomax
June 19 Hospira Receives Favorable Court Decision on Eloxatin
June 19 Pharmaceutical Company Manager Sentenced For Off-Label Marketing
June 22 Merck & Co., Inc. Statement on Medicare Part D Assistance
June 22 Vical Receives Milestone Payment From Merck & Co., Inc.
June 22 NeurogesX and Astellas Enter Commercialization Agreement for Qutenza
June 22 Merck and Schering-Plough Receive Request for Additional Information from FTC Regarding Proposed Merger
June 22 PhRMA Statement on the Health Care Reform Agreement
June 22 Biogen Idec Announces First Patient Enrolled in the Global Phase III Study of PEGylated Interferon Beta-1a for Relapsing Multiple Sclerosis
June 22 KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10-K
June 23 Merck Prices $4.25 Billion Debt Offering
June 23 Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration
June 23 Cell Genesys Announces Tender Offer Results While Continuing to Pursue Strategic Alternatives
June 23 Deductibility of Prescription Drug Ads May Be Under Threat
June 23 GSK and Chroma Therapeutics Form Alliance to Develop Novel Macrophage-Targeted Drugs
June 23 Mass. AG Martha Coakley?s Office Files Complaint Against Drug Manufacturer Wyeth
June 23 PharmaLive.com Launches New Pipeline Report
June 24 Medifacts Acquires Spacelabs Healthcare Clinical Trials Services Division
June 24 Takeda Announces Completion of Tender Offer for All Outstanding Shares of IDM Pharma, Inc.
June 24 Faes Farma and Pfizer Are Negotiating Semi Exclusive Licences for Bilastine in Certain Countries
June 24 Teva Pharmaceuticals Issues Statement in Response to Federal Trade Commission Claims on Patent Settlements
June 25 Baxter to Acquire Continuous Renal Replacement Therapy Business from Edwards Lifesciences
June 25 Novo Growth Equity Expands Team, and Will Invest Up to $200M Per Year
June 25 Sen. Grassley Seeks Information About Medical School Policies for Disclosure of Financial Ties
June 25 Uluru Discussions to Acquire York Pharma, plc Are Currently Terminated
June 25 ONGLYZA (Saxagliptin) Receives Positive Opinion in Europe for the Treatment of Type 2 Diabetes
June 26 U.S. Marshals Seize Drug Products Manufactured by Caraco Pharmaceutical Laboratories Ltd.
June 26 Caraco Pharmaceutical Laboratories, Ltd. Updates on Financial Position
June 26 CHMP Issue Opinions
June 26 Announcement of Establishment of a Holding Company in the U.S.
June 26 Novo Nordisk Reaches Settlement With the Danish Authorities Regarding Oil-for-Food Activities
June 26 Boston Scientific Announces Retirement of Jim Tobin and Appointment of Ray Elliott as New President and CEO
June 28 Sanofi-aventis Stands Behind the Safety of Lantus
June 28 Jerini AG (DE) - Ad hoc: Jerini AG to Wind Down its Preclinical Programs
June 29 A Side Effect of Michael Jackson’s Tragic Death – Consumer Health Education
June 29 Bayer Schering Pharma Extends Research Portfolio in the Field of Cancer-Related Targets
June 29 Simponi (Golimumab) Receives Positive Opinion from Chmp for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
June 29 ChemGenex to Seek Voluntary De-Listing From NASDAQ and to Restructure Board to Reflect Compliance Needs
June 29 Christian Lajoux Appointed President for sanofi-aventis in France
June 29 UCB Brings Neupro Back to All Patients in Europe
June 29 FDA Sends Romark Laboratories Warning Letter About Statements on Alinia Sales
June 29 FDA Reviews Mailer from Millennium Pharmaceuticals for Velcade
June 30 Sanofi-Aventis Presents New R&D Model Project to Boost Innovation
June 30 Centocor Ortho Biotech Inc. Awarded $1.67 Billion Patent Jury Verdict from Abbott Laboratories
June 30 BioSante Pharmaceuticals and Cell Genesys Sign Definitive Merger Agreement
June 30 UCB (BE) - UCB and Biogen Idec Discontinue Phase II Clinical Trial of CDP323
June 30 Collegium Pharmaceutical Announces the Sale of AllerNaze to Lupin
June 30 Pfizer Discontinues Phase 3 Trial of Sutent® in Metastatic Colorectal Cancer

Pharma Industry News Archive

2009: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov
2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

MedNotes
Advertisement

(web1)